CLINIGEN ERYTHROPOIETIN HUMAN SERUM CONTROLS 1,2,3— 510(k) K894943

Substantially Equivalent

Amgen, Inc.

FDA 510(k) clearance K894943 for CLINIGEN ERYTHROPOIETIN HUMAN SERUM CONTROLS 1,2,3, Substantially Equivalent on 1989-10-10. Applicant: Amgen, Inc..

Clearance details

Applicant: Amgen, Inc.
Product code: Code GGT
Advisory panel: Hematology
Date received: 1989-08-03
Decision date: 1989-10-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Thousand Oaks, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.